Ventyx Biosciences Inc
- Stock Issuer and Owners
Ventyx Biosciences Inc |
Ticker | VTYX |
CIK # | 0001851194 |
CUSIP | 92332V107 |
Sector | Life Sciences - Pharmaceutical Preparations |
Address | 662 Encinitas Blvd, Ste 250, Encinitas, CA 92024 |
Source |
[EDGAR]
|
Form 13F Holdings |
Firm |
Period |
DFND |
Voting |
Shares |
FMR LLC |
[2023-03-31]
|
DFND |
7,604,120.0 |
7,604,341.0 |
Citadel Advisors LLC |
[2023-03-31]
|
DFND |
3,033,723.0 |
3,033,723.0 |
Price T Rowe Associates Inc /MD/ |
[2023-03-31]
|
SOLE |
474,514.0 |
2,670,141.0 |
Capital International Investors |
[2023-03-31]
|
DFND |
2,377,784.0 |
2,377,784.0 |
venBio Partners LLC |
[2023-03-31]
|
SOLE |
2,298,833.0 |
2,298,833.0 |
BlackRock Inc. |
[2023-03-31]
|
SOLE |
2,026,212.0 |
2,048,601.0 |
Avidity Partners Management LP |
[2023-03-31]
|
SOLE |
1,917,800.0 |
1,917,800.0 |
Vanguard Group Inc |
[2023-03-31]
|
SOLE |
0.0 |
1,745,283.0 |
Janus Henderson Group PLC |
[2023-03-31]
|
DFND |
0.0 |
1,598,416.0 |
RTW Investments LP |
[2023-03-31]
|
SOLE |
1,388,881.0 |
1,388,881.0 |
Goldman Sachs Group Inc |
[2023-03-31]
|
DFND |
1,350,530.0 |
1,350,540.0 |
Lord Abbett & Co LLC |
[2023-03-31]
|
SOLE |
1,129,749.0 |
1,262,000.0 |
Point72 Asset Management LP |
[2023-03-31]
|
DFND |
0.0 |
1,069,400.0 |
Holocene Advisors LP |
[2023-03-31]
|
SOLE |
1,036,513.0 |
1,036,513.0 |
Driehaus Capital Management LLC |
[2023-03-31]
|
SOLE |
776,713.0 |
936,121.0 |
Wellington Management Group LLP |
[2023-03-31]
|
DFND |
0.0 |
870,505.0 |
Boxer Capital, LLC |
[2023-03-31]
|
OTR |
850,000.0 |
850,000.0 |
Redmile Group LLC |
[2023-03-31]
|
SOLE |
815,774.0 |
815,774.0 |
TCG Crossover Management LLC |
[2023-03-31]
|
SOLE |
815,724.0 |
815,724.0 |
Qiming US Ventures Management LLC |
[2023-03-31]
|
SOLE |
746,370.0 |
746,370.0 |
Pictet Asset Management Sa |
[2023-03-31]
|
DFND |
1.0 |
744,725.0 |
Deerfield Management Company LP Series C |
[2023-03-31]
|
DFND |
617,000.0 |
617,000.0 |
Vivo Capital LLC |
[2023-03-31]
|
SOLE |
602,075.0 |
602,075.0 |
State Street Corp |
[2023-03-31]
|
DFND |
563,232.0 |
599,827.0 |
Morgan Stanley |
[2023-03-31]
|
DFND |
549,821.0 |
595,876.0 |
OrbiMed Advisors LLC |
[2023-03-31]
|
DFND |
195,000.0 |
585,000.0 |
T. Rowe Price Investment Management, Inc. |
[2023-03-31]
|
SOLE |
172,725.0 |
564,636.0 |
Geode Capital Management LLC |
[2023-03-31]
|
DFND |
537,142.0 |
537,142.0 |
Artal Group S.A. |
[2023-03-31]
|
DFND |
535,812.0 |
535,812.0 |
Adage Capital Partners GP LLC |
[2023-03-31]
|
SOLE |
504,915.0 |
504,915.0 |
Prev | Page 1 | Next
|
{"search": "/search", "clicked": "/clicked", "portfolio_add": "/portfolio-add", "portfolio_remove": "/portfolio-remove", "portfolio_create": "/portfolio-create", "portfolio_activate": "/portfolio-activate", "portfolio_delete": "/portfolio-delete", "portfolio_rename": "/portfolio-rename", "portfolio_color": "/portfolio-color", "home_filter": "/home-filter", "htmlspeed": "/htmlspeed", "add_tag_firm": "/add-tag-firm", "add_tag_click": "/add-tag-click", "copy_aum": "/copy-aum", "stripe_checkout": "/stripe-checkout", "update_card": "/update-card"}
{"uid": 120464008, "pid": -1, "pid_a": [], "name": "", "email": "", "blacklist_f": false, "paywall_f": false, "paywall_n": 0, "random_n": 0}
False
163490246